DIFFERENCES IN NOREPINEPHRINE LEVELS IN DIFFERENT VASCULAR BEDS IN CONGESTIVE-HEART-FAILURE

被引:4
作者
EICHHORN, EJ
HATFIELD, BA
MARCOUX, L
机构
[1] UNIV TEXAS,SW MED CTR,DALLAS,TX 75216
[2] DALLAS VET ADM HOSP,DEPT INTERNAL MED,DIV CARDIOL,DALLAS,TX 75216
关键词
D O I
10.1016/0002-9149(93)90450-Q
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Congestive heart failure is a progressive disorder of systolic and diastolic ventricular dysfunction that results in reduced forward flow and increased filling pressures. In dilated cardiomyopathy due to ischemic or nonischemic etiologies, the resultant systolic and diastolic dysfunction results in pulmonary and systemic congestion, and activation of compensatory mechanisms to help maintain blood pressure and oxygenation.1-4 In congestive heart failure, aortic and cardiac baroreceptors are "reset" so that they lose their chronic inhibitory effect on sympathetic nerve traffic, and this results in chronic sympathetic activation and a state of vasoconstriction. 1-4 Plasma norepinephrine, a marker of sympathetic nervous system activation,2,3 is increased in congestive heart failure and is an independent predictor of mortality.5 Increases in plasma norepinephririe obtained from a peripheral vein have been used in several trials to examine both the effect of drug administration on neurohormonal activation and its prognostic value in predicting death in patients with heart failure.2,5. Despite its use as a marker of sympathetic activation, it is unclear if plasma norepinephrine obtained from a peripheral vein best represents cardiac sympathetic activation or if norepinephrine obtained from other sites best represents sympathetic stimulation at the cardiac postsynaptic terminal. Because the coronary sinus drains most of the effluent from the heart, we hypothesized that coronary sinus or transmyocardial (coronary sinus - aortic) norepinephrine would best represent myocardial adrenergic stimulation. Because sudden death is increased in patients with elevated sympathetic activation,2,4,5 and because it is unclear if systemic or cardiac sympathetic activation, or both, may be responsible for this phenomena, we believed it was important to examine which measure of norepinephrine would best reflect myocardial sympathetic activation. This is especially cogent because sympathetic activation may be different from 1 organ system to another.6-8 Because there is no "gold standard" for myocardial adrenergic stimulation, we assumed heart rate to be a reflection of effective cardiac adrenergic activation. Because parasympathetic withdrawal is a feature of congestive heart failure, the predominant effect on heart rate would be from the sympathetic nervous system.9. © 1993.
引用
收藏
页码:442 / 446
页数:5
相关论文
共 10 条
[1]   PARASYMPATHETIC WITHDRAWAL IS AN INTEGRAL COMPONENT OF AUTONOMIC IMBALANCE IN CONGESTIVE-HEART-FAILURE - DEMONSTRATION IN HUMAN-SUBJECTS AND VERIFICATION IN A PACED CANINE MODEL OF VENTRICULAR FAILURE [J].
BINKLEY, PF ;
NUNZIATA, E ;
HAAS, GJ ;
NELSON, SD ;
CODY, RJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1991, 18 (02) :464-472
[2]  
BRISTOW M R, 1988, European Heart Journal, V9, P35
[3]   PLASMA NOREPINEPHRINE AS A GUIDE TO PROGNOSIS IN PATIENTS WITH CHRONIC CONGESTIVE HEART-FAILURE [J].
COHN, JN ;
LEVINE, TB ;
OLIVARI, MT ;
GARBERG, V ;
LURA, D ;
FRANCIS, GS ;
SIMON, AB ;
RECTOR, T .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (13) :819-823
[4]   THE PARADOX OF BETA-ADRENERGIC-BLOCKADE FOR THE MANAGEMENT OF CONGESTIVE-HEART-FAILURE [J].
EICHHORN, EJ .
AMERICAN JOURNAL OF MEDICINE, 1992, 92 (05) :527-538
[5]   THE NEUROHUMORAL AXIS IN CONGESTIVE HEART-FAILURE [J].
FRANCIS, GS ;
GOLDSMITH, SR ;
LEVINE, TB ;
OLIVARI, MT ;
COHN, JN .
ANNALS OF INTERNAL MEDICINE, 1984, 101 (03) :370-377
[6]   NOREPINEPHRINE SPILLOVER TO PLASMA IN PATIENTS WITH CONGESTIVE-HEART-FAILURE - EVIDENCE OF INCREASED OVERALL AND CARDIORENAL SYMPATHETIC NERVOUS ACTIVITY [J].
HASKING, GJ ;
ESLER, MD ;
JENNINGS, GL ;
BURTON, D ;
JOHNS, JA ;
KORNER, PI .
CIRCULATION, 1986, 73 (04) :615-621
[7]   DIRECT EVIDENCE FROM INTRANEURAL RECORDINGS FOR INCREASED CENTRAL SYMPATHETIC OUTFLOW IN PATIENTS WITH HEART-FAILURE [J].
LEIMBACH, WN ;
WALLIN, BG ;
VICTOR, RG ;
AYLWARD, PE ;
SUNDLOF, G ;
MARK, AL .
CIRCULATION, 1986, 73 (05) :913-919
[8]  
PACKER M, 1987, CIRCULATION, V75, P80
[9]   DIFFERENTIAL CONTROL OF ADRENAL AND RENAL SYMPATHETIC-NERVE ACTIVITY DURING HEMORRHAGIC HYPOTENSION IN RATS [J].
VICTOR, RG ;
THOREN, P ;
MORGAN, DA ;
MARK, AL .
CIRCULATION RESEARCH, 1989, 64 (04) :686-694
[10]   STIMULATION OF SKIN SYMPATHETIC-NERVE DISCHARGE BY CENTRAL COMMAND - DIFFERENTIAL CONTROL OF SYMPATHETIC OUTFLOW TO SKIN AND SKELETAL-MUSCLE DURING STATIC EXERCISE [J].
VISSING, SF ;
SCHERRER, U ;
VICTOR, RG .
CIRCULATION RESEARCH, 1991, 69 (01) :228-238